Skip To Main Content
RTW Investments on Muck Rack

RTW Investments

As seen in: Yahoo Finance, Benzinga, KTLA-TV (Los Angeles, CA), KDVR-TV (Denver, CO), StreetInsider, Buffalo News, ADVFN, KTVI-TV (St. Louis, MO), This is Money, WHTM-TV (Harrisburg, PA) and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to RTW Investments’s profile

Articles by RTW Investments

ALURW Allurion Technologies Inc (ID)

|
By RTW Investments
| ADVFN
false0001964979NONENONE0001964979alur:CommonStockParValue00001PerShareMember 2026-07-212026-07-21 0001964979 2026-07-212026-07-21 0001964979alur:WarrantsToPurchase000378787SharesOfCommonStockEachAtAnExercisePriceOf303750PerShareOfCommonStockMember 2026-07-212026-07-21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21,...
Open in Who Shared Issue with article?

NYU Abu Dhabi and RTW Investments Announce Strategic Collaboration to Advance Healthcare and Life Sciences Innovation

|
By RTW Investments
| myMotherLode.com Verified
Partnership will deliver executive programs and convene global investors, policymakers, and experts to strengthen the region’s healthcare ecosystem NYU Abu Dhabi and RTW Investments, LP (“RTW”) today announced a strategic collaboration to advance executive education, thought leadership, and cross-sector engagement in healthcare, biotechnology, and life sciences across the region.
Open in Who Shared View Duplicates (25) Issue with article?

NYC VC-BACKED BOARD ACADEMY 4

|
By Delaware Court, RTW Investments
| regfox.com
The Honorable J. Travis Laster was sworn in as Vice Chancellor of the Court of Chancery on October 9, 2009. Prior to his appointment, he was one of the founding partners of Abrams & Laster LLP, a corporate law boutique specializing in high stakes litigation involving Delaware corporations and other business entities, and advising on transactional matters carrying a significant risk of litigation.
Open in Who Shared Issue with article?

Form 424B3 ALLURION TECHNOLOGIES,

|
By RTW Investments
| StreetInsider
Filed Pursuant to Rule 424(b)(3) Registration No. 333-279902 Prospectus Supplement No. 2 (To Prospectus dated October 7, 2024) ALLURION TECHNOLOGIES, INC. Up to 65,211,325 Shares of Common Stock This prospectus supplement no. 2 (this “Prospectus Supplement”) amends and supplements the prospectus dated October 7, 2024 (as supplemented or amended from time to time, the “Prospectus”) which forms part of our Registration Statement on Form S-1 (Registration Statement No. 333-279902).
Open in Who Shared View Duplicates (2) Issue with article?

RTW Biotech Opportunities’ 5th Anniversary

|
By RTW Investments, Woody Stileman
| sharesmagazine.co.uk
RNS Number : 4682K RTW Biotech Opportunities Ltd 01 November 2024 LEI: 549300Q7EXQQH6KF7Z84 01 November 2024 RTW Biotech Opportunities Ltd RTW Biotech Opportunities' 5th Anniversary RTW Biotech Opportunities Ltd (the "Company"), a London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, today announces the passing of its fifth anniversary since listing on the London Stock Exchange (LSE) in October...
Open in Who Shared Issue with article?

RTW Biotech Opportunities Ltd Baroness Blackwood Appointed as Independent NED

|
By RTW Investments
| ADVFN
Register for streaming realtime charts, analysis tools, and prices.
Open in Who Shared View Duplicates (4) Issue with article?

Investment in Mirador Therapeutics & Santa Ana Bio

|
By RTW Investments
| sharesmagazine.co.uk
RNS Number : 6892U RTW Biotech Opportunities Ltd 02 July 2024 LEI: 549300Q7EXQQH6KF7Z84 2 July 2024 RTW Biotech Opportunities Ltd New Investments in Mirador Therapeutics & Santa Ana Bio RTW Biotech Opportunities Ltd (the "Company"), a London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to note investments in new private portfolio companies, Mirador Therapeutics ("Mirador") and Santa...
Open in Who Shared Issue with article?

Positive Data Announcement - Avidity Biosciences

|
By RTW Investments
| sharesmagazine.co.uk
LEI: 549300Q7EXQQH6KF7Z84 13 June 2024 RTW Biotech Opportunities Ltd Positive Clinical Data Announcement by Largest Portfolio Holding - Avidity Biosciences • Avidity Biosciences announced "unprecedented" AOC 1020 data from Phase 1/2 clinical trial • Avidity plans to accelerate its registrational plans RTW Biotech Opportunities Ltd (the "Company"), a London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences...
Open in Who Shared Issue with article?

RTW Biotech Opportunities Ltd New Investment: Obsidian Therapeutics

|
By RTW Investments
| ADVFN
Register for streaming realtime charts, analysis tools, and prices.
Open in Who Shared Issue with article?

New Investment: Obsidian Therapeutics

|
By RTW Investments
| sharesmagazine.co.uk
LEI: 549300Q7EXQQH6KF7Z84 05 April 2024 RTW Biotech Opportunities Ltd New Investment in Obsidian Therapeutics, Inc.
Open in Who Shared Issue with article?

PSD Bank Rhein-Ruhr eG

|
By Janus Henderson Investors, RTW Investments, Cash Equivalents As
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update Issuer: Immunic AG / Key word(s): Quarter Results/Quarterly / Interim Statement Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update 08.05.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Immunic, Inc.
Open in Who Shared View Duplicates (225) Issue with article?

PSD Bank Rhein-Ruhr eG

|
By RTW Investments, Cash Equivalents, Investments as
| Sparda-Bank web.Börsenforum
Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update Issuer: Immunic, Inc. / Key word(s): Annual Results Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update 22.02.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Immunic, Inc.
Open in Who Shared View Duplicates (154) Issue with article?

Form 4 CARGO Therapeutics, Inc. For: Jan 12 Filed by: RTW INVESTMENTS, LP

|
By RTW Investments, Roderick Wong
| StreetInsider
Tweet Share E-mail 0 shares FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Expires: December 31, 2014 Estimated average burden hours per response: 0.5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
Open in Who Shared View Duplicates (697) Issue with article?

RTW Biotech Opportunities Ltd Monthly Valuation Update, December Factsheet (5941Z)

|
By RTW Investments
| ADVFN
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Open in Who Shared View Duplicates (2) Issue with article?

RTW Biotech Opportunities Ltd Investment Update (9421Y)

|
By RTW Investments
| ADVFN
Register for streaming realtime charts, analysis tools, and prices.
Open in Who Shared View Duplicates (3) Issue with article?

Form 8-K - Current report

|
By RTW Investments, VHCP Management EG, VHCP Management III, VR Adviser
| ADVFN
false 0001655759 0001655759 2023-11-24 2023-11-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 24, 2023 Arvinas, Inc.
Open in Who Shared View Duplicates (2) Issue with article?

RTW Biotech Opportunities Ltd Monthly Valuation Update, October Factsheet (1436T)

|
By RTW Investments
| ADVFN
Register for real-time alerts, custom portfolio, and market movers Share Name Share Symbol Market Type Share ISIN Share Description Rtw Biotech Opportunities Ltd LSE:RTWG London Ordinary Share GG00BKTRRM22 ORD NPV (GBP) Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade 0.00 0.0% 89.30 85.00 93.60 0.00 00:00:00 Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap Trust,ex Ed,religious,charty 2.17M -5.29M -0.0249 -36.02...
Open in Who Shared View Duplicates (4) Issue with article?

RTW Biotech Opportunities Ltd Monthly Valuation Update, Sep Factsheet, Q3 Letter (0048Q)

|
By RTW Investments
| ADVFN
Rtw Biotech Opportunities (LSE:RTW) Intraday Stock Chart Friday 13 October 2023 TIDMRTW RNS Number : 0048Q RTW Biotech Opportunities Ltd 13 October 2023 LEI: 549300Q7EXQQH6KF7Z84 13 October 2023 RTW Biotech Opportunities Ltd Monthly Valuation Update, September Factsheet & Third Quarter Letter -0.9% NAV movement for the month RTW Biotech Opportunities Ltd (the "Company") announces that the unaudited net asset value attributable to the ordinary shares of the Company at the close of business on...
Open in Who Shared View Duplicates (4) Issue with article?

RTW Biotech Opportunities Ltd Director Declaration (5644O)

|
By RTW Investments
| ADVFN
Rtw Biotech Opportunities (LSE:RTWG) Intraday Stock Chart Tuesday 3 October 2023 TIDMRTW RNS Number : 5644O RTW Biotech Opportunities Ltd 03 October 2023 LEI: 549300Q7EXQQH6KF7Z84 03 October 2023 RTW Biotech Opportunities Ltd (the "Company") Director Declaration In accordance with Listing Rule 9.6.14(2), the Company advises that Paul Le Page, a non-executive director of the Company, has been appointed as an independent non-executive director of NextEnergy Solar Fund Limited, a LSE listed FTSE...
Open in Who Shared View Duplicates (2) Issue with article?

RTW Biotech Opportunities Ltd Monthly Valuation Update & August Factsheet (5062M)

|
By RTW Investments
| ADVFN
Rtw Biotech Opportunities (LSE:RTW) Intraday Stock Chart Friday 15 September 2023 TIDMRTW RNS Number : 5062M RTW Biotech Opportunities Ltd 15 September 2023 LEI: 549300Q7EXQQH6KF7Z84 15 September 2023 RTW Biotech Opportunities Ltd Monthly Valuation Update & August Factsheet -4.4% NAV movement for the month RTW Biotech Opportunities Ltd (the "Company") announces that the unaudited net asset value attributable to the ordinary shares of the Company at the close of business on 31 August 2023 (the...
Open in Who Shared Issue with article?

RTW Biotech Opportunities Ltd Update on Largest Core Portfolio Position (4384M)

|
By RTW Investments
| ADVFN
Rtw Biotech Opportunities (LSE:RTW) Intraday Stock Chart Thursday 14 September 2023 TIDMRTW RNS Number : 4384M RTW Biotech Opportunities Ltd 14 September 2023 LEI: 549300Q7EXQQH6KF7Z84 14 September 2023 RTW Biotech Opportunities Ltd Update on Largest Core Portfolio Position -- Rocket Pharmaceuticals Reaches Alignment with FDA on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease -- On 13 September, Rocket also announced an underwritten public offering of 7,812,500 shares of its common...
Open in Who Shared View Duplicates (3) Issue with article?

RTW Biotech Opportunities Ltd Half-year Report

|
By RTW Investments, commercialisation Cardiovascular, A Degenerative, Peter S Fong
| ADVFN
Rtw Biotech Opportunities (LSE:RTWG) Intraday Stock Chart Wednesday 13 September 2023 TIDMRTW RNS Number : 2172M RTW Biotech Opportunities Ltd 13 September 2023 LEI: 549300Q7EXQQH6KF7Z84 13 September 2023 RTW Biotech Opportunities Ltd Interim Report for the period ended 30 June 2023 Strong NAV performance, significantly outperforming benchmark indices RTW Biotech Opportunities Ltd (the "Group"), the London Stock Exchange-Premium listed investment company focused on identifying transformative...
Open in Who Shared View Duplicates (2) Issue with article?

RTW Biotech Opportunities Ltd Additional Investment in Portfolio Company

|
By RTW Investments
| ADVFN
Rtw Biotech Opportunities (LSE:RTWG) Intraday Stock Chart Monday 4 September 2023 TIDMRTW RNS Number : 2844L RTW Biotech Opportunities Ltd 04 September 2023 LEI: 549300Q7EXQQH6KF7Z84 04 September 2023 RTW Biotech Opportunities Ltd Additional Investment in Portfolio Company -- RTW Biotech Opportunities participates in a $100M Series D in Beta Bionics, Inc., a portfolio company RTW Biotech Opportunities Ltd (the "Company"), a London Stock Exchange-listed investment fund focused on identifying...
Open in Who Shared View Duplicates (3) Issue with article?

Form 4 ROCKET PHARMACEUTICALS, For: Aug 28 Filed by: RTW INVESTMENTS, LP

|
By RTW Investments, Roderick Wong
| StreetInsider
Tweet Share E-mail 0 shares FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Expires: December 31, 2014 Estimated average burden hours per response: 0.5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
Open in Who Shared View Duplicates (10) Issue with article?

Statement of changes in beneficial ownership of securities

|
By RTW Investments, Roderick Wong
| ADVFN
Form 4 - Statement of changes in beneficial ownership of securities August 30 2023 - 04:15PM Edgar (US Regulatory) SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 Check this box if no longer subject...
Open in Who Shared View Duplicates (47) Issue with article?

RTW Biotech Opportunities Ltd Monthly Valuation Update & July Factsheet

|
By RTW Investments
| ADVFN
Rtw Biotech Opportunities (LSE:RTWG) Intraday Stock Chart Monday 14 August 2023 TIDMRTW RNS Number : 1316J RTW Biotech Opportunities Ltd 14 August 2023 LEI: 549300Q7EXQQH6KF7Z84 14 August 2023 RTW Biotech Opportunities Ltd Monthly Valuation Update & July Factsheet +0.16% NAV movement for the month RTW Biotech Opportunities Ltd (the "Company") announces that the unaudited net asset value attributable to the ordinary shares of the Company at the close of business on 31 July 2023 (the "NAV") was...
Open in Who Shared View Duplicates (3) Issue with article?

ALLURION TECHNOLOGIES, INC. Active Stake (FormSC13D) - Allurion Technologies (NYSE:ALUR)

|
By RTW Investments
| Benzinga
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 ALLURION TECHNOLOGIES HOLDINGS, INC.
Open in Who Shared Issue with article?

Stock Market | Financial News | myMotherLode.com

|
By RTW Investments
| myMotherLode.com Verified
Former CureVac Chief Scientific Officer to Lead Research & Development of CNS Disease Therapies Yarrow Biotechnology, Inc. (“Yarrow”), an RTW Investments, LP (“RTW”) -incubated company developing nucleic acid therapeutics and other modalities for severe, genetically defined diseases including those of the central nervous system (“CNS”), today announced the appointment of Dr. Igor Splawski as Chief Scientific Officer.
Open in Who Shared View Duplicates (41) Issue with article?

RTW Biotech Opportunities Ltd Portfolio Company Update: Apogee Therapeutics IPO

|
By RTW Investments
| ADVFN
Rtw Biotech Opportunities (LSE:RTW) Intraday Stock Chart Monday 17 July 2023 TIDMRTW RNS Number : 1453G RTW Biotech Opportunities Ltd 17 July 2023 LEI: 549300Q7EXQQH6KF7Z84 17 July 2023 RTW Biotech Opportunities Ltd Portfolio Company Update: Apogee Therapeutics IPO Apogee executes successful $300 million IPO RTW Biotech Opportunities Ltd (the "Company"), a London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the...
Open in Who Shared View Duplicates (2) Issue with article?

RTW Biotech Opportunities Ltd Monthly Valuation Update, Factsheet & Q2 Letter

|
By RTW Investments
| ADVFN
Rtw Biotech Opportunities (LSE:RTWG) Intraday Stock Chart Monday 17 July 2023 TIDMRTW RNS Number : 1452G RTW Biotech Opportunities Ltd 17 July 2023 LEI: 549300Q7EXQQH6KF7Z84 17 July 2023 RTW Biotech Opportunities Ltd Monthly Valuation Update, June Factsheet & Second Quarter Letter -2.4% NAV movement for the month RTW Biotech Opportunities Ltd (the "Company") announces that the unaudited net asset value attributable to the ordinary shares of the Company at the close of business on 30 June 2023...
Open in Who Shared View Duplicates (2) Issue with article?

RTW Biotech Opportunities Ltd Capital Allocation Plans from Prometheus Sale

|
By RTW Investments
| ADVFN
Rtw Biotech Opportunities (LSE:RTW) Intraday Stock Chart Wednesday 5 July 2023 TIDMRTW RNS Number : 9962E RTW Biotech Opportunities Ltd 05 July 2023 LEI: 549300Q7EXQQH6KF7Z84 5 July 2023 RTW Biotech Opportunities Ltd Capital allocation plans from Prometheus Biosciences sale including share buyback RTW Biotech Opportunities Ltd ("RTW Biotech Opportunities" or the "Company"), a London Stock Exchange-listed investment company focused on identifying transformative assets with high growth...
Open in Who Shared View Duplicates (2) Issue with article?

RTW Biotech Opportunities Ltd Portfolio Company Update: Tourmaline Bio

|
By RTW Investments
| ADVFN
TIDMRTW RTW Biotech Opportunities Ltd 30 June 2023 LEI: 549300Q7EXQQH6KF7Z84 30 June 2023 RTW Biotech Opportunities Ltd Portfolio Company Update: Tourmaline Bio Tourmaline Bio enters a definitive agreement to merge with Talaris Therapeutics and start trading on Nasdaq RTW Biotech Opportunities Ltd (the "Company"), a London Stock Exchange-listed investment fund focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to note the...
Open in Who Shared View Duplicates (2) Issue with article?

RTW Venture Fund Limited Change of Name

|
By RTW Investments
| ADVFN
Rtw Biotech Opportunities (LSE:RTWG) Intraday Stock Chart Tuesday 27 June 2023 TIDMRTW RNS Number : 9402D RTW Venture Fund Limited 27 June 2023 LEI: 549300Q7EXQQH6KF7Z84 27 June 2023 RTW VENTURE FUND LIMITED (the "Company") Change of Name RTW Venture Fund , a London Stock Exchange-listed investment fund focused on identifying transformative assets with high growth potential across the life sciences sector is pleased to announce that the Company has changed its name to RTW Biotech...
Open in Who Shared View Duplicates (3) Issue with article?

RTW Venture Fund Limited Result of AGM

|
By RTW Investments
| ADVFN
Rtw Venture (LSE:RTWG) Intraday Stock Chart Wednesday 21 June 2023 TIDMRTW RNS Number : 4932D RTW Venture Fund Limited 21 June 2023 LEI: 549300Q7EXQQH6KF7Z84 21 June 2023 RTW VENTURE FUND LIMITED (the "Company") Results of the Annual General Meeting ("AGM") The Company is pleased to announce that, at the fourth AGM held at 14.00 BST today, 21 June 2023, each of the Resolutions was duly passed without amendment.
Open in Who Shared View Duplicates (3) Issue with article?

RTW Venture Fund Limited Monthly Valuation Update & Factsheet

|
By RTW Investments
| ADVFN
Rtw Venture (LSE:RTWG) Intraday Stock Chart Friday 12 May 2023 TIDMRTW RNS Number : 1612Z RTW Venture Fund Limited 12 May 2023 LEI: 549300Q7EXQQH6KF7Z84 12 May 2023 RTW Venture Fund Limited Monthly Valuation Update & Factsheet +13% NAV movement RTW Venture Fund Limited (the "Company") announces that the unaudited net asset value attributable to the ordinary shares of the Company at the close of business on 30 April 2023 (the "NAV") was US$358.6 million, or US$1.69 per ordinary share, an...
Open in Who Shared View Duplicates (2) Issue with article?
|
By RTW Investments, Fischer served
| chase.com
Enter Symbol or Keyword(s) Timeframe to Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update 7:16 AM EDT 5/11/2023 - Comtex MONTREAL and CHARLOTTE, N.C., May 11, 2023 (Canada NewsWire via COMTEX News Network) -- - NDA submission for etripamil in patients with PSVT currently on track for 3Q23 - Company to host virtual KOL event focused on etripamil for the potential treatment of AFib-RVR on Monday, May 22, 2023 - Topline data from...
Open in Who Shared View Duplicates (150) Issue with article?

RTW Venture Fund Limited Portfolio Company Update: Acelyrin IPO

|
By RTW Investments
| ADVFN
Rtw Venture (LSE:RTW) Intraday Stock Chart Tuesday 9 May 2023 TIDMRTW RNS Number : 6755Y RTW Venture Fund Limited 09 May 2023 LEI: 549300Q7EXQQH6KF7Z84 09 May 2023 RTW Venture Fund Limited Portfolio Company Update: Acelyrin IPO Acelyrin Prices Upsized $540 Million IPO RTW Venture Fund Limited (the "Company"), a London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors, is...
Open in Who Shared View Duplicates (3) Issue with article?

RTW Venture Fund Limited Annual Financial Report

|
By RTW Investments
| ADVFN
Rtw Venture (LSE:RTW) Intraday Stock Chart Tuesday 2 May 2023 TIDMRTW RNS Number : 9746X RTW Venture Fund Limited 02 May 2023 LEI: 549300Q7EXQQH6KF7Z84 2 May 2023 RTW Venture Fund Limited Annual Financial Report Year ended 31 December 2022 A tagged copy of the above document was submitted to the National Storage Mechanism on 28 April 2023 and is available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism For Further Information: RTW Investments, LP +44 (0)20 7959 6361...
Open in Who Shared View Duplicates (4) Issue with article?

RTW Venture Fund Limited New Investment in Abdera Therapeutics

|
By RTW Investments, Abdera Therapeutics
| ADVFN
Rtw Venture (LSE:RTW) Intraday Stock Chart Wednesday 26 April 2023 TIDMRTW RNS Number : 4384X RTW Venture Fund Limited 26 April 2023 LEI: 549300Q7EXQQH6KF7Z84 26 April 2023 RTW Venture Fund Limited New Investment in Abdera Therapeutics RTW participates in Series B Round in Abdera Therapeutics -- RTW Venture Fund Limited announces a new portfolio company, Abdera Therapeutics -- The proceeds from the financing are int ended to support Abdera's radiotherapy pipeline of potentially best-in-class...
Open in Who Shared View Duplicates (4) Issue with article?

RTW Venture Fund Limited March Factsheet & First Quarter Letter

|
By RTW Investments
| ADVFN
Rtw Venture (LSE:RTW) Intraday Stock Chart Monday 24 April 2023 TIDMRTW RNS Number : 2631X RTW Venture Fund Limited 24 April 2023 LEI: 549300Q7EXQQH6KF7Z84 24 April 2023 RTW Venture Fund Limited March Factsheet & First Quarter Letter -2.7% NAV Return for the Quarter Ended 31 March 2023 RTW Venture Fund Limited (the "Company"), the London Stock Exchange Premium Listed investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and...
Open in Who Shared View Duplicates (3) Issue with article?

RTW Venture Fund Limited Portfolio Company Update: Prometheus Biosciences

|
By RTW Investments
| ADVFN
Rtw Venture (LSE:RTWG) Intraday Stock Chart Monday 17 April 2023 TIDMRTW RNS Number : 3472W RTW Venture Fund Limited 17 April 2023 LEI: 549300Q7EXQQH6KF7Z84 17 April 2023 RTW Venture Fund Limited Portfolio Company Update: Prometheus Biosciences Prometheus Biosciences enters a definitive agreement to be acquired by Merck RTW Venture Fund Limited (the "Company" or "RTW Venture Fund"), a London Stock Exchange-listed investment fund focused on identifying transformative assets with high growth...
Open in Who Shared View Duplicates (3) Issue with article?

RTW Investments, LP Issues Statement Regarding Cutera's Special Meeting of Stockholders

|
By RTW Investments
| KTLA-TV (Los Angeles, CA) Verified
RTW Investments Supports Good Corporate Governance Requests the Board continue with the Special Meeting , /PRNewswire/ -- RTW Investments, LP ("RTW"), which manages funds holding approximately 9.3% of the outstanding shares of Cutera, Inc. (the "Company") (Nasdaq: CUTR), today announced that it was in favor of the Company holding the previously-called Special Meeting of Stockholders (the "Special Meeting") for the purpose of reconstituting the Board of Directors (the "Board") of the Company.
Open in Who Shared View Duplicates (158) Issue with article?

RTW Venture Fund Limited Appointment of Numis as Joint Broker

|
By RTW Investments
| ADVFN
Rtw Venture (LSE:RTW) Intraday Stock Chart Thursday 6 April 2023 TIDMRTW RNS Number : 6369V RTW Venture Fund Limited 06 April 2023 LEI: 549300Q7EXQQH6KF7Z84 6 April 2023 RTW Venture Fund Limited Appointment of Numis as Joint Broker RTW Venture Fund Limited (the "Company"), a London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to announce that it has appointed Numis with immediate...
Open in Who Shared View Duplicates (2) Issue with article?

Form 4 Renovacor, Inc. For: Dec 01 Filed by: RTW INVESTMENTS, LP

|
By RTW Investments, Roderick Wong
| StreetInsider
Form 4 Renovacor, Inc. For: Dec 01 Filed by: RTW INVESTMENTS, LP April 5, 2023 4:31 PM EDT Tweet Share E-mail News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Open in Who Shared View Duplicates (699) Issue with article?

RTW Venture Fund Limited Annual Financial Report

|
By - As, RTW Investments, Peter S Fong, Gotham Makker
| ADVFN
Rtw Venture (LSE:RTWG) Intraday Stock Chart Friday 31 March 2023 TIDMRTW RNS Number : 8473U RTW Venture Fund Limited 31 March 2023 LEI: 549300Q7EXQQH6KF7Z84 31 March 2023 RTW Venture Fund Limited Annual Report and Audited Financial Statements for the Year Ended 31 December 2022 Benchmark outperformance, realising significant value through successful portfolio company IPOs and disposals RTW Venture Fund Limited (the "Group" or the "Company"), a London Stock Exchange-listed investment company...
Open in Who Shared View Duplicates (2) Issue with article?

Milestone Pharmaceuticals Announces $125 Million Strategic Financing with RTW Investments to Support the Advancement of Etripamil for PSVT

|
By RTW Investments
| Longview News-Journal Verified
-  Proceeds from strategic financing together with year-end cash resources expected to fund operations into mid-2025 including etripamil NDA submission and launch in PSVT -  The combination of etripamil's strong clinical results with this strategic financing lays the foundation to deliver a therapy that empowers patients to treat supraventricular tachycardia attacks outside the emergency department , /PRNewswire/ -- Milestone Pharmaceuticals Inc.
Open in Who Shared View Duplicates (33) Issue with article?

Form 4 Milestone Pharmaceutical For: Mar 22 Filed by: RTW INVESTMENTS, LP

|
By RTW Investments, Roderick Wong
| StreetInsider
Form 4 Milestone Pharmaceutical For: Mar 22 Filed by: RTW INVESTMENTS, LP March 24, 2023 4:31 PM EDT Tweet Share E-mail Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Open in Who Shared View Duplicates (308) Issue with article?

Stock Market | The Antlers American | poteaudailynews.com

|
By RTW Investments
| The Antlers American Verified
RTW Charitable Foundation today announced a $50,000 donation to the Syrian American Medical Society (“SAMS”) Foundation, a global medical relief organization working on the front lines of crisis relief in Syria and beyond to save lives and alleviate suffering, to provide emergency relief to victims of the 7.8 magnitude earthquake that struck Southern Turkey along the border of Syria on February 6.
Open in Who Shared View Duplicates (17) Issue with article?
Show More